Nature Reviews Neurology, Published online: 14 April 2026; doi:10.1038/s41582-026-01211-0 The apolipoprotein E ε3 Christchurch variant provides remarkable resilience against Alzheimer disease by limiting tau propagation and suppressing neuroinflammation. New research reveals that this protection extends to the periphery, where ‘lipid-loaded’ extracellular vesicles stabilize the blood–brain barrier, which offers a novel systemic mechanism for developing potent disease-modifying therapies.
Nature Reviews Neurology published a clinical update in Neurology on 14 Apr 2026. The item focuses on Alzheimer disease protection from the periphery. Open the detail page to review the full original feed content.